How pharmaceutical companies profit from drugs for rare diseases


Hughes, DA and Poletti-Hughes, J ORCID: 0000-0001-5959-2141 (2016) How pharmaceutical companies profit from drugs for rare diseases. The Conversation.

WarningThere is a more recent version of this item available.
Access the full-text of this item by clicking on the Open Access link.
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 24 Oct 2016 09:24
Last Modified: 19 Jan 2023 07:27
Open Access URL: https://theconversation.com/how-pharmaceutical-com...
URI: https://livrepository.liverpool.ac.uk/id/eprint/3003927

Available Versions of this Item

CORE (COnnecting REpositories)